RFID 在药品市场机会、成长动力、产业趋势分析与预测 2024 - 2032 年

RFID in Pharmaceuticals Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年09月03日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球 RFID 药品市场资料达到 38 亿美元，2024 年至 2032 年复合年增长率将达到 7.7%。。这些标籤可以储存有关药品的详细信息，包括批次号、有效期和製造详细信息，确保全面的可追溯性。将 RFID 与区块链技术结合对于确保药品供应链的安全性越来越受到关注。区块链提供了一个不可变的分类账，记录 RFID 标籤产品的每笔交易和移动，确保透明度并防止篡改或诈欺。

这种组合增强了追踪资讯的可信度，有助于验证药品的真实性。 RFID 标籤产品领域占据市场主导地位，到 2023 年价值将达到 17 亿美元。每个标籤都可以储存唯一识别码和附加资料，确保可以追踪产品从製造到销售点的整个过程。这种可追溯性对于防止假药和确保产品真实性至关重要，这是製药业的关键问题。

RFID标籤用途广泛，可应用于各种类型的药品，包括单一药品包装、托盘和医疗设备。这种多功能性允许对多个层级的库存进行全面追踪和管理，这对于製药公司和医疗保健提供者来说是一个显着的优势。预计到2032 年，晶片式RFID 市场将占据市场主导地位。。这些标籤支援加密和身份验证协议，提供卓越的防伪保护，这对于确保药品的完整性至关重要。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	38亿美元
预测值	73 亿美元
复合年增长率	7.7%

这些特征有助于细分市场的成长。 RFID技术透过提供药品位置和状态的即时可见性来提高医疗保健供应链管理的效率和准确性，从而减少错误并改善库存管理。这反过来又增加了他们的市场需求。 2023 年北美 RFID 在药品市场的规模将超过 15 亿美元，预计在分析时间内复合年增长率为 6.6%。

北美对医疗保健基础设施的大量投资有助于扩大 RFID 系统在药品领域的应用。对改善医疗服务和病人安全的关注推动了先进追踪和追踪技术的采用。由于製药业的高水准创新和基础设施准备就绪，北美在采用 RFID 等先进技术方面处于领先地位，推动了该地区的市场成长。

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Alien Technology, LLC
AVERY DENNISON CORPORATION
Blue Vector
CCL Healthcare
Checkpoint Systems, Inc.
Denso Wave
GAO Group
Impinj Inc.
Intermec, Inc.
Tageos
Terso Solutions Inc.
Zebra Technologies Corp.

简介目录

Product Code: 11207

The Global RFID In Pharmaceuticals Market reached a valuation of USD 3.8 billion in 2023 and will expand at a CAGR of 7.7% from 2024 to 2032. Modern RFID tags now offer enhanced data storage, longer read ranges, and greater durability. These tags can store detailed information about pharmaceutical products, including batch numbers, expiration dates, and manufacturing details, ensuring comprehensive traceability. Integrating RFID with blockchain technology is gaining traction to secure the pharmaceutical supply chain. Blockchain provides an immutable ledger that records every transaction and movement of RFID-tagged products, ensuring transparency and preventing tampering or fraud.

This combination enhances the credibility of tracking information and helps verify the authenticity of pharmaceuticals. The RFID tags product segment dominated the market, valued at USD 1.7 billion in 2023. RFID tags provide detailed and accurate information about pharmaceutical products throughout the supply chain. Each tag can store a unique identifier and additional data, ensuring that products can be tracked from manufacturing to the point of sale. This traceability is essential for preventing counterfeit drugs and ensuring product authenticity, a critical concern in the pharmaceutical industry.

RFID tags are versatile and can be applied to various types of pharmaceutical products, including individual drug packages, pallets, and medical equipment. This versatility allows for comprehensive tracking and management of inventory at multiple levels, which is a significant advantage for pharmaceutical companies and healthcare providers. The chipped RFID segment is anticipated to dominate the market by 2032. Chipped RFID tags can store and process detailed information such as product IDs, batch numbers, and expiration dates, which is essential for traceability and regulatory compliance in the pharmaceutical industry. The tags support encryption and authentication protocols, offering superior protection against counterfeiting, which is crucial for ensuring the integrity of pharmaceutical products.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$3.8 Billion
Forecast Value	$7.3 Billion
CAGR	7.7%

These features contribute to segmental growth. RFID technology enhances the efficiency and accuracy of healthcare supply chain management by providing real-time visibility into the location and status of pharmaceutical products, thereby reducing errors and improving inventory management. This, in turn, increases their demand in the market. North America RFID in pharmaceuticals market size in 2023 was over USD 1.5 billion and is predicted to grow at a CAGR of 6.6% over the analysis timeframe.

Significant investments in healthcare infrastructure in North America contribute to the expansion of RFID systems in pharmaceuticals. The focus on improving healthcare delivery and patient safety drives the adoption of advanced tracking and tracing technologies. North America leads in the adoption of advanced technologies, including RFID, due to a high level of innovation and infrastructure readiness in the pharmaceutical sector, driving market growth in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing occurrence of counterfeit drugs
  - 3.2.1.2 Rising emphasis on optimization of supply chain
  - 3.2.1.3 Technological advancements in RFID technologies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High implementation cost of RFID systems
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Future market trends
3.7 GAP analysis
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 RFID tags
5.3 RFID readers
5.4 RFID middleware

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Chipped RFID
6.3 Chip-less RFID

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Drug track & tracing systems
7.3 Drug quality management
7.4 Other applications

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Drug manufacturers
8.3 Hospitals & clinics
8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa